These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ; J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436 [TBL] [Abstract][Full Text] [Related]
4. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121 [TBL] [Abstract][Full Text] [Related]
5. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases. Chan NY; Wai-Ling Ho L Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537 [TBL] [Abstract][Full Text] [Related]
6. Termination of electrocution-induced ventricular fibrillation by an implantable cardioverter defibrillator. Ginwalla M; Battula S; Dunn J; Lewis WR Pacing Clin Electrophysiol; 2010 Apr; 33(4):510-2. PubMed ID: 20015136 [TBL] [Abstract][Full Text] [Related]
7. Inappropriate shock delivery by implantable cardioverter defibrillator due to electrical interference with washing machine. Chongtham DS; Bahl A; Kumar RM; Talwar KK Int J Cardiol; 2007 May; 118(2):e44-5. PubMed ID: 17395291 [TBL] [Abstract][Full Text] [Related]
8. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port. Maagh P; Trappe HJ; Meissner A Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694 [TBL] [Abstract][Full Text] [Related]
9. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators. Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359 [TBL] [Abstract][Full Text] [Related]
10. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710 [TBL] [Abstract][Full Text] [Related]
11. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003 [TBL] [Abstract][Full Text] [Related]
12. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH; Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171 [TBL] [Abstract][Full Text] [Related]